Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT7 | O95251 | 20/20 | 0.62 |
| ▸ | KAT6A | Q92794 | 20/20 | 0.62 |
| ▸ | KAT6B | Q8WYB5 | 12/20 | 0.62 |
| ▸ | KAT5 | Q92993 | 9/20 | 0.62 |
| ▸ | KAT8 | Q9H7Z6 | 9/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21609033 | 0.89 | KAT6A (0.74) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL31605632 | 0.89 | KAT6A (0.74) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL21609236 | 0.86 | KAT6A (0.66) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL21660309 | 0.83 | KAT6A (0.57) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL30838425 | 0.82 | KAT7 (0.72) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL21609077 | 0.82 | KAT7 (0.72) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL21609083 | 0.80 | KAT7 (0.71) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL21609032 | 0.80 | KAT7 (0.57) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL31605634 | 0.80 | KAT7 (0.57) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL21660538 | 0.78 | KAT6A (0.61) | KAT7KAT6AKAT6BKAT5KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153710-A1 | Compounds | CTXT PTY LTD (AU) | 2022-05-19 | — | — | US | disclosed |
| US-20200039945-A1 | Compounds | CTXT PTY LIMITED (AU) | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153710-A1 | Compounds | SLC10A1, ABCB11, PCSK9 | KAT7 490/4885KAT6A 877/4885KAT6B 1005/4885 |
| US-20200039945-A1 | Compounds | SLC10A1, ABCB11, PCSK9 | KAT7 490/4885KAT6A 878/4885KAT6B 1007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.